3-iodobenzylguanidine has been researched along with Graft vs Host Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Békássy, AN; Dykes, JH; Garkavij, M; Gleisner, KS; Juliusson, G; Lenhoff, S; Ora, I; Scheding, S; Tennvall, J; Toporski, J; Turkiewicz, D | 1 |
1 other study(ies) available for 3-iodobenzylguanidine and Graft vs Host Disease
| Article | Year |
|---|---|
High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Cell Culture Techniques; Child; Child, Preschool; Cohort Studies; Combined Modality Therapy; Female; Graft vs Host Disease; Haplotypes; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Mesenchymal Stem Cell Transplantation; Neoplasm Recurrence, Local; Neuroblastoma; Radiopharmaceuticals; T-Lymphocytes; Transplantation Chimera | 2009 |